TBK1 knock-down, or treatment with TBK1-II, a drug that efficiently inhibits TBK1 and its close relative IKKε (IKBKE), suppressed growth of human HER2+ BC cells and induced cellular senescence. This evidence concerns the gene ERBB2 and breast cancer.